Quick Answer
DEXCOM INC reported Research And Development Expense of $599.10 million for the year ending 2025.
- DEXCOM INC showed an increase of +8.5% in Research And Development Expense from 2024 to 2025.
- This data is from DEXCOM INC's annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $5.43 million | Q3 2010: $6.16 million | Q1 2011: $6.27 million | Q2 2011: $7.02 million | Q3 2011: $8.23 million | Q1 2012: $9.40 million | Q2 2012: $10.00 million | Q3 2012: $10.30 million | Q1 2013: $9.30 million | Q2 2013: $11.10 million | Q3 2013: $11.80 million | Q1 2014: $14.50 million | Q2 2014: $14.80 million | Q3 2014: $18.50 million | Q1 2015: $19.80 million | Q2 2015: $24.40 million | Q3 2015: $64.80 million | Q1 2016: $32.20 million | Q2 2016: $36.30 million | Q3 2016: $43.90 million | Q1 2017: $48.10 million | Q2 2017: $45.30 million | Q3 2017: $43.30 million | Q1 2018: $44.80 million | Q2 2018: $47.20 million | Q3 2018: $50.10 million | Q1 2019: $59.00 million | Q2 2019: $69.00 million | Q3 2019: $66.70 million | Q1 2020: $73.10 million | Q2 2020: $79.90 million | Q3 2020: $87.70 million | Q1 2021: $109.40 million | Q2 2021: $129.10 million | Q3 2021: $128.80 million | Q1 2022: $135.90 million | Q2 2022: $121.70 million | Q3 2022: $110.30 million | Q1 2023: $119.00 million | Q2 2023: $119.30 million | Q3 2023: $131.40 million | Q1 2024: $141.50 million | Q2 2024: $136.00 million | Q3 2024: $135.40 million | Q1 2025: $145.20 million | Q2 2025: $148.20 million | Q3 2025: $157.50 million.
- Over the full 17 years of available data (2009 to 2025), DEXCOM INC's Research And Development Expense has grown by 4,091.3%.
- Historical annual values: Fiscal year 2025: $599.10 million | Fiscal year 2024: $552.40 million | Fiscal year 2023: $505.80 million | Fiscal year 2022: $484.20 million | Fiscal year 2021: $517.10 million | Fiscal year 2020: $359.90 million | Fiscal year 2019: $273.50 million | Fiscal year 2018: $199.70 million | Fiscal year 2017: $185.40 million | Fiscal year 2016: $156.10 million | Fiscal year 2015: $137.50 million | Fiscal year 2014: $69.40 million | Fiscal year 2013: $44.80 million | Fiscal year 2012: $38.30 million | Fiscal year 2011: $29.60 million | Fiscal year 2010: $23.20 million | Fiscal year 2009: $14.29 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: